PHP55 THE INFLUENCE OF COST-EFFECTIVENESS ISSUES OF THE APPRAISED ORPHAN DRUGS ON RECOMMENDATIONS OF AGENCY FOR HEALTH TECHNOLOGY ASSESSMENT IN POLAND (AHTAPOL)
May 1, 2011, 00:00 AM
10.1016/j.jval.2011.02.125
https://www.valueinhealthjournal.com/article/S1098-3015(11)00264-6/fulltext
Section Title :
Health Care Use & Policy Studies
Section Order :
648
First Page :
A21
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(11)00264-6&doi=10.1016/j.jval.2011.02.125